Rational Design, Pharmacomodulation, and Synthesis of Dual 5‑Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain

We report the synthesis of 46 tertiary amine-bearing N-alkylated benzo­[d]­imidazol-2­(3H)-ones, imidazo­[4,5-b]­pyridin-2­(3H)-ones, imidazo­[4,5-c]­pyridin-2­(3H)-ones, benzo­[d]­oxazol-2­(3H)-ones, oxazolo­[4,5-b]­pyridin-2­(3H)-ones and N,N′-dialkylated benzo­[d]­imidazol-2­(3H)-ones. These comp...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2015-10, Vol.58 (20), p.8066-8096
Main Authors: Deau, Emmanuel, Robin, Elodie, Voinea, Raluca, Percina, Nathalie, Satała, Grzegorz, Finaru, Adriana-Luminita, Chartier, Agnès, Tamagnan, Gilles, Alagille, David, Bojarski, Andrzej J, Morisset-Lopez, Séverine, Suzenet, Franck, Guillaumet, Gérald
Format: Article
Language:English
Subjects:
Animals
Blood-Brain Barrier
Brain - diagnostic imaging
Chemical Sciences
Drug Design
Image Processing, Computer-Assisted
Isotope Labeling
Ligands
Macaca mulatta
Positron-Emission Tomography
Radiopharmaceuticals - chemical synthesis
Radiopharmaceuticals - pharmacology
Receptor, Serotonin, 5-HT2A - drug effects
Receptors, Serotonin - drug effects
Serotonin Antagonists - chemical synthesis
Serotonin Antagonists - pharmacology
Structure-Activity Relationship
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a448t-8ffac12e40f4baee1e6117982a7f53be9cc80b860488201daa229128ead679993
cites cdi_FETCH-LOGICAL-a448t-8ffac12e40f4baee1e6117982a7f53be9cc80b860488201daa229128ead679993
container_end_page 8096
container_issue 20
container_start_page 8066
container_title Journal of medicinal chemistry
container_volume 58
creator Deau, Emmanuel
Robin, Elodie
Voinea, Raluca
Percina, Nathalie
Satała, Grzegorz
Finaru, Adriana-Luminita
Chartier, Agnès
Tamagnan, Gilles
Alagille, David
Bojarski, Andrzej J
Morisset-Lopez, Séverine
Suzenet, Franck
Guillaumet, Gérald
description We report the synthesis of 46 tertiary amine-bearing N-alkylated benzo­[d]­imidazol-2­(3H)-ones, imidazo­[4,5-b]­pyridin-2­(3H)-ones, imidazo­[4,5-c]­pyridin-2­(3H)-ones, benzo­[d]­oxazol-2­(3H)-ones, oxazolo­[4,5-b]­pyridin-2­(3H)-ones and N,N′-dialkylated benzo­[d]­imidazol-2­(3H)-ones. These compounds were evaluated against 5-HT7R, 5-HT2AR, 5-HT1AR, and 5-HT6R as potent dual 5-HT7/5-HT2A serotonin receptors ligands. A thorough study of the structure–activity relationship of the aromatic rings and their substituents, the alkyl chain length and the tertiary amine was conducted. 1-(4-(4-(4-Fluorobenzoyl)­piperidin-1-yl)­butyl)-1H-benzo­[d]­imidazol-2­(3H)-one (79) and 1-(6-(4-(4-fluorobenzoyl)­piperidin-1-yl)­hexyl)-1H-benzo­[d]­imidazol-2­(3H)-one (81) were identified as full antagonist ligands on cyclic adenosine monophosphate (cAMP, K B = 4.9 and 5.9 nM, respectively) and inositol monophosphate (IP1, K B = 0.6 and 16 nM, respectively) signaling pathways of 5-HT7R and 5-HT2AR. Both antagonists crossed the blood–brain barrier as evaluated with [18F] radiolabeled compounds [ 18 F]­79 and [ 18 F]­81 in a primate’s central nervous system using positron emission tomography. Both radioligands showed standard uptake values ranging from 0.8 to 1.1, a good plasmatic stability, and a distribution consistent with 5-HT7R and 5-HT2AR in the CNS.
doi_str_mv 10.1021/acs.jmedchem.5b00874
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03082898v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1728053252</sourcerecordid><originalsourceid>FETCH-LOGICAL-a448t-8ffac12e40f4baee1e6117982a7f53be9cc80b860488201daa229128ead679993</originalsourceid><addsrcrecordid>eNp9kdFq2zAYhc3YWLNubzCGLhuoU-m3bMuXXpsuhcBCl12NIX7bcuJiS6lkl_lur9CX6oPsSebEaW8Gu_pB5zvnCI7nfWR0xiiwC8zd7K5RRb5VzSzMKBUxf-VNWAjU54Ly196EUgAfIghOvHfO3VFKAwbBW-8EooAL4PHEe7rFtjIaa3KlXLXR52S1RdtgbhpTdPVBPCeoC_Kt1-12YBwxJbnqBkf45_fjoi-s-dW3tt-12FRakZichf5iHU8vhvOPCukoQzoltypXu9ZYkuoWN0ZXrnWHqvkD1t2hmmQ9-cHE9U9_NV-TmwY3ld6QShMkK1s12Cry2WKl33tvSqyd-nC8p9736_n6cuEvv365uUyXPnIuWl-UJeYMFKclz1AppiLG4kQAxmUYZCrJc0EzEVEuBFBWIAIkDITCIoqTJAlOvemYu8Va7vY_sL00WMlFupT7NxpQASIRD2xgz0Z2Z819p1wrm8rlqq5RK9M5yWIQNAwghAHlI5pb45xV5Us2o3K_thzWls9ry-Pag-3TsaHLBu3F9DzvANARONhNZ4eh3f8z_wITlLmD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1728053252</pqid></control><display><type>article</type><title>Rational Design, Pharmacomodulation, and Synthesis of Dual 5‑Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Deau, Emmanuel ; Robin, Elodie ; Voinea, Raluca ; Percina, Nathalie ; Satała, Grzegorz ; Finaru, Adriana-Luminita ; Chartier, Agnès ; Tamagnan, Gilles ; Alagille, David ; Bojarski, Andrzej J ; Morisset-Lopez, Séverine ; Suzenet, Franck ; Guillaumet, Gérald</creator><creatorcontrib>Deau, Emmanuel ; Robin, Elodie ; Voinea, Raluca ; Percina, Nathalie ; Satała, Grzegorz ; Finaru, Adriana-Luminita ; Chartier, Agnès ; Tamagnan, Gilles ; Alagille, David ; Bojarski, Andrzej J ; Morisset-Lopez, Séverine ; Suzenet, Franck ; Guillaumet, Gérald</creatorcontrib><description>We report the synthesis of 46 tertiary amine-bearing N-alkylated benzo­[d]­imidazol-2­(3H)-ones, imidazo­[4,5-b]­pyridin-2­(3H)-ones, imidazo­[4,5-c]­pyridin-2­(3H)-ones, benzo­[d]­oxazol-2­(3H)-ones, oxazolo­[4,5-b]­pyridin-2­(3H)-ones and N,N′-dialkylated benzo­[d]­imidazol-2­(3H)-ones. These compounds were evaluated against 5-HT7R, 5-HT2AR, 5-HT1AR, and 5-HT6R as potent dual 5-HT7/5-HT2A serotonin receptors ligands. A thorough study of the structure–activity relationship of the aromatic rings and their substituents, the alkyl chain length and the tertiary amine was conducted. 1-(4-(4-(4-Fluorobenzoyl)­piperidin-1-yl)­butyl)-1H-benzo­[d]­imidazol-2­(3H)-one (79) and 1-(6-(4-(4-fluorobenzoyl)­piperidin-1-yl)­hexyl)-1H-benzo­[d]­imidazol-2­(3H)-one (81) were identified as full antagonist ligands on cyclic adenosine monophosphate (cAMP, K B = 4.9 and 5.9 nM, respectively) and inositol monophosphate (IP1, K B = 0.6 and 16 nM, respectively) signaling pathways of 5-HT7R and 5-HT2AR. Both antagonists crossed the blood–brain barrier as evaluated with [18F] radiolabeled compounds [ 18 F]­79 and [ 18 F]­81 in a primate’s central nervous system using positron emission tomography. Both radioligands showed standard uptake values ranging from 0.8 to 1.1, a good plasmatic stability, and a distribution consistent with 5-HT7R and 5-HT2AR in the CNS.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.5b00874</identifier><identifier>PMID: 26348247</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Blood-Brain Barrier ; Brain - diagnostic imaging ; Chemical Sciences ; Drug Design ; Image Processing, Computer-Assisted ; Isotope Labeling ; Ligands ; Macaca mulatta ; Positron-Emission Tomography ; Radiopharmaceuticals - chemical synthesis ; Radiopharmaceuticals - pharmacology ; Receptor, Serotonin, 5-HT2A - drug effects ; Receptors, Serotonin - drug effects ; Serotonin Antagonists - chemical synthesis ; Serotonin Antagonists - pharmacology ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2015-10, Vol.58 (20), p.8066-8096</ispartof><rights>Copyright © 2015 American Chemical Society</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a448t-8ffac12e40f4baee1e6117982a7f53be9cc80b860488201daa229128ead679993</citedby><cites>FETCH-LOGICAL-a448t-8ffac12e40f4baee1e6117982a7f53be9cc80b860488201daa229128ead679993</cites><orcidid>0000-0002-9930-7824 ; 0000-0003-1417-6333 ; 0000-0003-1394-1603 ; 0000-0003-4495-7755</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26348247$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://cnrs.hal.science/hal-03082898$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Deau, Emmanuel</creatorcontrib><creatorcontrib>Robin, Elodie</creatorcontrib><creatorcontrib>Voinea, Raluca</creatorcontrib><creatorcontrib>Percina, Nathalie</creatorcontrib><creatorcontrib>Satała, Grzegorz</creatorcontrib><creatorcontrib>Finaru, Adriana-Luminita</creatorcontrib><creatorcontrib>Chartier, Agnès</creatorcontrib><creatorcontrib>Tamagnan, Gilles</creatorcontrib><creatorcontrib>Alagille, David</creatorcontrib><creatorcontrib>Bojarski, Andrzej J</creatorcontrib><creatorcontrib>Morisset-Lopez, Séverine</creatorcontrib><creatorcontrib>Suzenet, Franck</creatorcontrib><creatorcontrib>Guillaumet, Gérald</creatorcontrib><title>Rational Design, Pharmacomodulation, and Synthesis of Dual 5‑Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>We report the synthesis of 46 tertiary amine-bearing N-alkylated benzo­[d]­imidazol-2­(3H)-ones, imidazo­[4,5-b]­pyridin-2­(3H)-ones, imidazo­[4,5-c]­pyridin-2­(3H)-ones, benzo­[d]­oxazol-2­(3H)-ones, oxazolo­[4,5-b]­pyridin-2­(3H)-ones and N,N′-dialkylated benzo­[d]­imidazol-2­(3H)-ones. These compounds were evaluated against 5-HT7R, 5-HT2AR, 5-HT1AR, and 5-HT6R as potent dual 5-HT7/5-HT2A serotonin receptors ligands. A thorough study of the structure–activity relationship of the aromatic rings and their substituents, the alkyl chain length and the tertiary amine was conducted. 1-(4-(4-(4-Fluorobenzoyl)­piperidin-1-yl)­butyl)-1H-benzo­[d]­imidazol-2­(3H)-one (79) and 1-(6-(4-(4-fluorobenzoyl)­piperidin-1-yl)­hexyl)-1H-benzo­[d]­imidazol-2­(3H)-one (81) were identified as full antagonist ligands on cyclic adenosine monophosphate (cAMP, K B = 4.9 and 5.9 nM, respectively) and inositol monophosphate (IP1, K B = 0.6 and 16 nM, respectively) signaling pathways of 5-HT7R and 5-HT2AR. Both antagonists crossed the blood–brain barrier as evaluated with [18F] radiolabeled compounds [ 18 F]­79 and [ 18 F]­81 in a primate’s central nervous system using positron emission tomography. Both radioligands showed standard uptake values ranging from 0.8 to 1.1, a good plasmatic stability, and a distribution consistent with 5-HT7R and 5-HT2AR in the CNS.</description><subject>Animals</subject><subject>Blood-Brain Barrier</subject><subject>Brain - diagnostic imaging</subject><subject>Chemical Sciences</subject><subject>Drug Design</subject><subject>Image Processing, Computer-Assisted</subject><subject>Isotope Labeling</subject><subject>Ligands</subject><subject>Macaca mulatta</subject><subject>Positron-Emission Tomography</subject><subject>Radiopharmaceuticals - chemical synthesis</subject><subject>Radiopharmaceuticals - pharmacology</subject><subject>Receptor, Serotonin, 5-HT2A - drug effects</subject><subject>Receptors, Serotonin - drug effects</subject><subject>Serotonin Antagonists - chemical synthesis</subject><subject>Serotonin Antagonists - pharmacology</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kdFq2zAYhc3YWLNubzCGLhuoU-m3bMuXXpsuhcBCl12NIX7bcuJiS6lkl_lur9CX6oPsSebEaW8Gu_pB5zvnCI7nfWR0xiiwC8zd7K5RRb5VzSzMKBUxf-VNWAjU54Ly196EUgAfIghOvHfO3VFKAwbBW-8EooAL4PHEe7rFtjIaa3KlXLXR52S1RdtgbhpTdPVBPCeoC_Kt1-12YBwxJbnqBkf45_fjoi-s-dW3tt-12FRakZichf5iHU8vhvOPCukoQzoltypXu9ZYkuoWN0ZXrnWHqvkD1t2hmmQ9-cHE9U9_NV-TmwY3ld6QShMkK1s12Cry2WKl33tvSqyd-nC8p9736_n6cuEvv365uUyXPnIuWl-UJeYMFKclz1AppiLG4kQAxmUYZCrJc0EzEVEuBFBWIAIkDITCIoqTJAlOvemYu8Va7vY_sL00WMlFupT7NxpQASIRD2xgz0Z2Z819p1wrm8rlqq5RK9M5yWIQNAwghAHlI5pb45xV5Us2o3K_thzWls9ry-Pag-3TsaHLBu3F9DzvANARONhNZ4eh3f8z_wITlLmD</recordid><startdate>20151022</startdate><enddate>20151022</enddate><creator>Deau, Emmanuel</creator><creator>Robin, Elodie</creator><creator>Voinea, Raluca</creator><creator>Percina, Nathalie</creator><creator>Satała, Grzegorz</creator><creator>Finaru, Adriana-Luminita</creator><creator>Chartier, Agnès</creator><creator>Tamagnan, Gilles</creator><creator>Alagille, David</creator><creator>Bojarski, Andrzej J</creator><creator>Morisset-Lopez, Séverine</creator><creator>Suzenet, Franck</creator><creator>Guillaumet, Gérald</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-9930-7824</orcidid><orcidid>https://orcid.org/0000-0003-1417-6333</orcidid><orcidid>https://orcid.org/0000-0003-1394-1603</orcidid><orcidid>https://orcid.org/0000-0003-4495-7755</orcidid></search><sort><creationdate>20151022</creationdate><title>Rational Design, Pharmacomodulation, and Synthesis of Dual 5‑Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain</title><author>Deau, Emmanuel ; Robin, Elodie ; Voinea, Raluca ; Percina, Nathalie ; Satała, Grzegorz ; Finaru, Adriana-Luminita ; Chartier, Agnès ; Tamagnan, Gilles ; Alagille, David ; Bojarski, Andrzej J ; Morisset-Lopez, Séverine ; Suzenet, Franck ; Guillaumet, Gérald</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a448t-8ffac12e40f4baee1e6117982a7f53be9cc80b860488201daa229128ead679993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Blood-Brain Barrier</topic><topic>Brain - diagnostic imaging</topic><topic>Chemical Sciences</topic><topic>Drug Design</topic><topic>Image Processing, Computer-Assisted</topic><topic>Isotope Labeling</topic><topic>Ligands</topic><topic>Macaca mulatta</topic><topic>Positron-Emission Tomography</topic><topic>Radiopharmaceuticals - chemical synthesis</topic><topic>Radiopharmaceuticals - pharmacology</topic><topic>Receptor, Serotonin, 5-HT2A - drug effects</topic><topic>Receptors, Serotonin - drug effects</topic><topic>Serotonin Antagonists - chemical synthesis</topic><topic>Serotonin Antagonists - pharmacology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deau, Emmanuel</creatorcontrib><creatorcontrib>Robin, Elodie</creatorcontrib><creatorcontrib>Voinea, Raluca</creatorcontrib><creatorcontrib>Percina, Nathalie</creatorcontrib><creatorcontrib>Satała, Grzegorz</creatorcontrib><creatorcontrib>Finaru, Adriana-Luminita</creatorcontrib><creatorcontrib>Chartier, Agnès</creatorcontrib><creatorcontrib>Tamagnan, Gilles</creatorcontrib><creatorcontrib>Alagille, David</creatorcontrib><creatorcontrib>Bojarski, Andrzej J</creatorcontrib><creatorcontrib>Morisset-Lopez, Séverine</creatorcontrib><creatorcontrib>Suzenet, Franck</creatorcontrib><creatorcontrib>Guillaumet, Gérald</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deau, Emmanuel</au><au>Robin, Elodie</au><au>Voinea, Raluca</au><au>Percina, Nathalie</au><au>Satała, Grzegorz</au><au>Finaru, Adriana-Luminita</au><au>Chartier, Agnès</au><au>Tamagnan, Gilles</au><au>Alagille, David</au><au>Bojarski, Andrzej J</au><au>Morisset-Lopez, Séverine</au><au>Suzenet, Franck</au><au>Guillaumet, Gérald</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rational Design, Pharmacomodulation, and Synthesis of Dual 5‑Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2015-10-22</date><risdate>2015</risdate><volume>58</volume><issue>20</issue><spage>8066</spage><epage>8096</epage><pages>8066-8096</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>We report the synthesis of 46 tertiary amine-bearing N-alkylated benzo­[d]­imidazol-2­(3H)-ones, imidazo­[4,5-b]­pyridin-2­(3H)-ones, imidazo­[4,5-c]­pyridin-2­(3H)-ones, benzo­[d]­oxazol-2­(3H)-ones, oxazolo­[4,5-b]­pyridin-2­(3H)-ones and N,N′-dialkylated benzo­[d]­imidazol-2­(3H)-ones. These compounds were evaluated against 5-HT7R, 5-HT2AR, 5-HT1AR, and 5-HT6R as potent dual 5-HT7/5-HT2A serotonin receptors ligands. A thorough study of the structure–activity relationship of the aromatic rings and their substituents, the alkyl chain length and the tertiary amine was conducted. 1-(4-(4-(4-Fluorobenzoyl)­piperidin-1-yl)­butyl)-1H-benzo­[d]­imidazol-2­(3H)-one (79) and 1-(6-(4-(4-fluorobenzoyl)­piperidin-1-yl)­hexyl)-1H-benzo­[d]­imidazol-2­(3H)-one (81) were identified as full antagonist ligands on cyclic adenosine monophosphate (cAMP, K B = 4.9 and 5.9 nM, respectively) and inositol monophosphate (IP1, K B = 0.6 and 16 nM, respectively) signaling pathways of 5-HT7R and 5-HT2AR. Both antagonists crossed the blood–brain barrier as evaluated with [18F] radiolabeled compounds [ 18 F]­79 and [ 18 F]­81 in a primate’s central nervous system using positron emission tomography. Both radioligands showed standard uptake values ranging from 0.8 to 1.1, a good plasmatic stability, and a distribution consistent with 5-HT7R and 5-HT2AR in the CNS.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>26348247</pmid><doi>10.1021/acs.jmedchem.5b00874</doi><tpages>31</tpages><orcidid>https://orcid.org/0000-0002-9930-7824</orcidid><orcidid>https://orcid.org/0000-0003-1417-6333</orcidid><orcidid>https://orcid.org/0000-0003-1394-1603</orcidid><orcidid>https://orcid.org/0000-0003-4495-7755</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2015-10, Vol.58 (20), p.8066-8096
issn 0022-2623
1520-4804
language eng
recordid cdi_hal_primary_oai_HAL_hal_03082898v1
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Animals
Blood-Brain Barrier
Brain - diagnostic imaging
Chemical Sciences
Drug Design
Image Processing, Computer-Assisted
Isotope Labeling
Ligands
Macaca mulatta
Positron-Emission Tomography
Radiopharmaceuticals - chemical synthesis
Radiopharmaceuticals - pharmacology
Receptor, Serotonin, 5-HT2A - drug effects
Receptors, Serotonin - drug effects
Serotonin Antagonists - chemical synthesis
Serotonin Antagonists - pharmacology
Structure-Activity Relationship
title Rational Design, Pharmacomodulation, and Synthesis of Dual 5‑Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T11%3A26%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rational%20Design,%20Pharmacomodulation,%20and%20Synthesis%20of%20Dual%205%E2%80%91Hydroxytryptamine%207%20(5-HT7)/5-Hydroxytryptamine%202A%20(5-HT2A)%20Receptor%20Antagonists%20and%20Evaluation%20by%20%5B18F%5D-PET%20Imaging%20in%20a%20Primate%20Brain&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Deau,%20Emmanuel&rft.date=2015-10-22&rft.volume=58&rft.issue=20&rft.spage=8066&rft.epage=8096&rft.pages=8066-8096&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.5b00874&rft_dat=%3Cproquest_hal_p%3E1728053252%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a448t-8ffac12e40f4baee1e6117982a7f53be9cc80b860488201daa229128ead679993%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1728053252&rft_id=info:pmid/26348247&rfr_iscdi=true